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Cell Biology
Isolation of interleukin 2-induced immediate-early genes
(differential cloning/human T cells/cytokine-responsive genes)
CAROL BEADLING*, KiRK W. JOHNSONtt, AND KENDALL A. SMITHt§
Departments of *Biochemistry and tMedicine, Dartmouth Medical School, Hanover, NH 03755-3833
Communicated by Zanvil A. Cohn, September 17, 1992
ABSTRACT Clonal expansion of antigen-reactive T lym-
phocytes is driven by the lymphokine interleukin 2 (IL-2). To
further elucidate the mechanisms of IL-2 action, we have
utilized a differential hybridization procedure to clone IL-2-
induced immediate-early genes from an IL-2-stimulated hu-
man T-cell cDNA library. To increase the frequency of IL-2-
induced transcripts represented in the library, the protein
synthesis inhibitor cycloheximide was included during the 2-hr
IL-2 stimulation to superinduce gene expression, and the
uridine analogue 4-thiouridine was utilized to enable selective
purification of newly synthesized transcripts. From the en-
riched library, we have isolated eight IL-2-induced genes, six
of which represent previously unrecognized human sequences.
Northern blot analysis revealed that the induction of seven of
the genes is specific to the IL-2-mediated G1 "progression"
phase of the cell cycle, in that only one gene is also induced
during the T-celi receptor-triggered Gr-G1 "competence"
phase. These results indicate that the effects of IL-2 are
mediated by the specific induction of a number of immediate-
early genes and provide a means with which to further delineate
the mechanisms whereby IL-2 stimulates T-lymphocyte prolif-
eration and differentiation. The methods described in this
report should also be of general utility in the dissection of the
signaling pathways activated by diverse cytokine receptors.
Over the past several years, seminal studies have established
that T-cell activation occurs as a two-step process (1).
Quiescent lymphocytes are stimulated initially by antigen-
presenting cells via the T-cell antigen receptor/CD3 complex
(TCR/CD3), together with accessory molecules such as
CD28 (2), which enables the cells to produce and respond to
interleukin 2 (IL-2) (3-6). Subsequently, the interaction of
IL-2 with its receptor (IL-2R) promotes cell cycle progression
and DNA replication (3, 4, 6-8). Thus, these two cell surface
receptor systems trigger different cellular processes: the
G0r-G1 transition (cell cycle competence) is activated by the
TCR/CD3 complex, whereas G1 progression to S phase (cell
cycle progression) is promoted by the IL-2R (7-9). Consistent
with these findings, the early biochemical events triggered by
these two receptor systems are distinct. TCR/CD3 stimula-
tion activates rapid tyrosine-specific phosphorylation of sev-
eral substrates (10-12), followed by phosphatidylinositol (PI)
hydrolysis and subsequent elevation of intracellular free
calcium and activation of the calcium- and phospholipid-
dependent serine/threonine-specific protein kinase C (PKC)
(13, 14). Tyrosine-specific (12, 15) and serine/threonine-
specific (16) phosphorylation also occurs within minutes of
IL-2R activation. However, IL-2-mediated signal transduc-
tion does not involve PI hydrolysis (17), elevations in intra-
cellular calcium (18), or PKC activation (19, 20). Moreover,
the serine/threonine-specific kinase Raf-1 is activated by the
IL-2R but not by the TCR/CD3 complex (21, 22).
Since the TCR/CD3 complex and the IL-2R activate
distinct early biochemical signaling pathways and effect
changes in separate stages of the cell cycle, it may be
assumed that some of the genes stimulated by the two
receptor pathways will also be different. To date, a significant
number of early genes have been shown to be expressed in
response to TCR/CD3 complex activation, including several
previously characterized protooncogenes and cytokines (23,
24), as well as a substantial number of previously unrecog-
nized genes (25). Several ofthe cellular protooncogenes, such
as c-fos, c-myc, and c-raf-1, are expressed after both TCR/
CD3 and IL-2R activation (22, 23, 26), while induction of the
c-myb gene is unique to IL-2R stimulation (8). To enable
further analysis of the genetic program expressed during the
course of lymphocyte activation, we have sought to identify
additional IL-2-induced early genes.
Although it is relatively straightforward to determine
whether previously characterized genes are expressed in
response to receptor triggering, it is somewhat more difficult
to identify new genes, given the background of the many
genes already expressed constitutively. One approach that
has enabled the isolation of a number of growth factor-
induced genes is based on the differential hybridization of
cDNA libraries, using probes obtained from activated cells
compared with quiescent cells (27-29). However, this
method is limited by its sensitivity, detecting only those
transcripts that are expressed in relatively high abundance, at
a level >500 copies per cell (27). To augment the level ofgene
expression above this threshold, cycloheximide (CHX) has
been used, as the inhibition of protein synthesis superinduces
the expression of a number of genes, especially those that
have short-lived transcripts (27-29). To further enrich for
newly induced genes, a thiol selection procedure has been
employed whereby growth factor-induced RNA transcripts
are selectively labeled with thiol-derivatized uridine, en-
abling subsequent purification of the labeled transcripts by
phenylmercury agarose chromatography (30, 31). In this
manner, the newly synthesized transcripts may be separated
from the transcripts derived from housekeeping-type genes
that were present prior to stimulation (30, 31). This thiol-
labeling procedure was used in the generation of a cDNA
library from newly synthesized RNA of human peripheral
blood T cells stimulated for 2 hr with IL-2 and CHX. By
differential screening of this library, eight IL-2-induced genes
have been isolated, six ofwhich are newly characterized, and
only one of which is also expressed after TCR/CD3 stimu-
lation. These results indicate that IL-2 induces a set of genes
that is distinct from the TCR/CD3-stimulated "competence"
genes. Moreover, the procedures described in this report
should have wide applicability in the selective isolation of
genes expressed as a result of diverse signaling pathways and
Abbreviations: IL, interleukin; IL-2R, IL-2 receptor; CHX, cyclo-
heximide; CR, cytokine-responsive; TCR, T-cell antigen receptor.
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should open the way toward the further identification and
characterization of cytokine-responsive (CR) genes.
METHODS
Chemicals. Homogeneous recombinant IL-2 was provided
by Takeda (Osaka) as a 1.0 mg/ml solution in ammonium
acetate buffer (pH 5.0). 4-Thiouridine was obtained from
Sigma, and phenylmercury agarose (Affi-Gel 501) was from
Bio-Rad. Phorbol 12,13-dibutyrate was obtained from Con-
solidated Midland (Brewster, NY) and solubilized in di-
methyl sulfoxide to yield a stock concentration of 5.0 mg/ml.
[3H-methynlThymidine (10 Ci/mmol; 1 Ci = 37 GBq) was
purchased from ICN, and [5,6-3H]uridine (48 Ci/mmol) was
from Amersham.
Cell Culture. Human peripheral blood mononuclear cells
were isolated by Ficoll/Hypaque discontinuous centrifuga-
tion and cultured at 106 cells per ml in complete medium
comprised of RPMI 1640 (GIBCO) supplemented with 10%
heat-inactivated (56°C, 30 min) calf serum (Sterile Systems,
Logan, UT), 50 ,ug of gentamycin per ml, 200 pg of L-gluta-
mine per ml, and 50 units of penicillin per ml. T cells were
activated by stimulation of the CD3 component of the T-cell
receptor complex with an anti-CD3-reactive monoclonal an-
tibody (OKT3, 1:10,000 dilution, Ortho Pharmaceuticals) in
the presence or absence of 10 ug of CHX per ml, and DNA
synthesis was monitored at 48-52 hr by adding 0.5 ACi of[3H]thymidine to aliquots (200 ,l1) of cell cultures in 96-well
microtiter plates. Cultures were harvested onto glass fiber
filters, radioactivity was assayed by liquid scintillation, and
[3H]thymidine incorporation was calculated as cpm per 104
cells per hr.
IL-2R-positive T-cell blasts were prepared by stimulation
of peripheral blood mononuclear cells with OKT3 for 3 days,
after which the cells were washed and replaced in culture for
an additional 11 days in the presence of 500 pM IL-2. The
cells were subsequently washed and placed in culture in the
absence ofIL-2 for 36 hr, followed by a 12-hr stimulation with
50 ng of phorbol 12,13-dibutyrate per ml to augment high-
affinity IL-2R expression. Cells were washed free of phorbol
12,13-dibutyrate and placed in culture for 12 hr prior to
restimulation. Such treatment enabled the generation of a
GO/Gl-synchronized cell population, comprised of >90o
T8-positive T lymphocytes (32).
cDNA Library Construction. Human IL-2R-positive T-cell
blasts were cultured in the presence of 1 nM IL-2, 10 Ag of
CHX per ml, 250 uM 4-thiouridine, and 2.5 ,uCi of [3H]uridine
per ml for 2 hr. The cells were then lysed in guanidium
thiocyanate and total cellular RNA was isolated as described
(33). To purify thiol-labeled transcripts, the total RNA was
dissolved in loading buffer consisting of 0.05 M NaOAc (pH
5.5), 0.1% SDS, 0.15 M NaCl, and 4 mM EDTA and heated
at 65°C for 5 min. The RNA was then cooled on ice and
adsorbed for 10 min at room temperature to a phenylmercury
agarose (Affi-Gel 501) column, which had been equilibrated
in the RNA loading buffer. Approximately 400 ,ug of RNA
was applied per 1-ml packed column resin. The unbound
eluate was collected, reheated, and reapplied to the column.
The column was then washed with the RNA loading buffer,
followed by loading buffer containing 0.5 M NaCl to remove
nonspecifically adhering transcripts. The thiol-labeled RNA
was eluted in loading buffer containing 50 mM 2-mercapto-
ethanol (31). The thiol-selected RNA was precipitated in
ethanol and used in the synthesis of Not I primer/adaptor-
primed cDNA, utilizing the Riboclone cDNA synthesis sys-
tem (Promega) according to the manufacturer's instructions.
After addition of EcoRI adaptors (Promega), Not I digestion,
and size selection for fragments >500 bp, the cDNA was
ligated directionally into an EcoRI- and Not I-digested
pBluescript II SK+ plasmid vector (Stratagene), followed by
transformation into Epicurian Escherichia coli XL1-blue
competent cells (Stratagene).
Colony Screening. Single-stranded 32P-labeled cDNA
probes were prepared from poly(A)+ RNA isolated from
human T-cell blasts stimulated for 2 hr with medium (un-
stimulated probe) or 1 nM IL-2 and 10 ug of CHX per ml
(stimulated probe). Total cellular RNA was prepared as
described (33), and poly(A)+ RNA was isolated by three
passages over an oligo(dT)-cellulose column (5 Prime -) 3
Prime, Inc.). First-strand cDNA synthesis was performed
with an oligo(dT12_18) primer (United States Biochemical),
using the Riboclone cDNA synthesis system (Promega) ac-
cording to the manufacturer's instructions, with the excep-
tion of dCTP at a final concentration of 35 pM and the
addition of 2.5 mCi of [32P]dCTP per ml. Hybridization was
carried out for 72-96 hr at 42°C in 50% formamide, with a final
probe concentration of =2 x 106 cpm/ml (34). Subsequent to
hybridization, filters were washed repeatedly at 62°C in 0.1 x
SSC (lx SSC = 0.15 M NaCl/0.015 M sodium citrate, pH
7.0) and 0.1% SDS and placed on film (Kodak XAR-5) with
DuPont Cronex intensifying screens overnight at -70°C.
Colonies that exhibited differential hybridization to the stim-
ulated and unstimulated probes after three independent
screens were isolated for further analysis.
Northern Blot Analysis. Total cellularRNA was isolated by
the guanidine thiocyanate method (9) and denatured in gly-
oxal and dimethyl sulfoxide, followed by fractionation on a
1% agarose gel in 0.01 M NaH2PO4 with 0.5 ,ug of ethidium
bromide per ml (35). To estimate sizes ofRNA transcripts, a
0.24- to 9.5-kb RNA ladder (Bethesda Research Laborato-
ries) was run alongside the cellular RNA samples. After
visualization under UV light, the RNA was transferred to
nitrocellulose by capillary transfer in lOx SSC. Plasmids
were purified from the clones of interest, and the Not I- and
EcoRI-excised inserts were 32P-labeled with random primers.
Hybridization was carried out in 50% formamide at 42°C for
48-72 hr, followed by repeated washes in O.lx SSC/0.1%
SDS at 56-620C (35). Filters were exposed to Kodak XAR-5
film with DuPont Cronex intensifying screens, and specific
bands were quantitated with an EC densitometer (E-C Ap-
paratus). Filters were normalized for RNA loading by hy-
bridization with a 1.2-kb fragment of the cDNA encoding the
cdc-like kinase, clk (36).
Sequence Analysis. Plasmids were isolated from the clones
of interest (37) and vector primers were used to sequence the
termini of the cDNA inserts, employing the Applied Biosys-
tems model 373ADNA sequencer. Further sequence analysis
was performed using a combination of exonuclease III-
generated nested deletions (38) and custom-designed oligo-
nucleotide primers. Searches of the GenBank and EMBL
data bases were performed with the FASTA program as
described (39).
RESULTS
Thiol-Labeled RNA Purification and cDNA Library Con-
struction. To construct the cDNA library, total cellular RNA
was fractionated by passage over a phenylmercury agarose
column, such that thiol-labeled transcripts were covalently
bound to the column, whereas unlabeled RNA was collected
in the column flow-through. Nonspecifically boundRNA was
removed from the column by low (0.15 M NaCl) and high (0.5
M NaCl) salt washes, and the thiol-labeled RNA was subse-
quently eluted in the presence of 50 mM 2-mercaptoethanol
(30, 31). In several such experiments, >90%o ofthe totalRNA
was recovered in the flow-through and nonspecifically bound
column fractions, whereas the labeled RNA was specifically
eluted with 2-mercaptoethanol. Thus, this purification re-
sulted in an =10-fold enrichment for newly synthesized[3H]uridine-labeled RNA, calculated by the increased spe-
cific activity of the recovered 3H-labeled transcripts (Fig.
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1A). The purification scheme was specific for thiol-labeled
transcripts, because when the 4-thiouridine was omitted from
the procedure, only 0.2% of the total [3H]RNA was recovered
in the 2-mercaptoethanol eluate. When the nonselected total
RNA was compared with the nonspecifically bound RNA and
thiol-selected RNA by Northern hybridization using a probe
encoding the known IL-2-induced immediate-early gene
c-myc (26), a marked increase in the relative abundance of
c-myc was observed in the thiol-selected RNA (Fig. 1B).
Therefore, this thiol-selected RNA, which constituted 7.5%
of the total cellular RNA, was used in the synthesis of an
oligo(dT)-primed cDNA library of -104 clones in the plasmid
vector pBluescript II SKI.
Northern Blot Analysis of Putative Clones. Differential
colony screening of -10% of the library yielded 18 putative
IL-2-induced genes, as assessed by greater hybridization to
single-stranded 32P-labeled cDNA probes generated from
2-hr IL-2- and CHX-treated versus unstimulated human
IL-2R-positive T-cell RNA. Inasmuch as CHX was included
in the library and probe preparation, it was essential to verify
that the differential expression of putative clones observed
upon colony screening was not due solely to the effects of this
drug. In addition, determination of the sizes and patterns of
induction of the RNA transcripts was necessary to enable
estimation of the redundancy of the clones. Therefore,
Northern blot analysis was performed with RNA isolated
from human IL-2R-positive T-cell blasts stimulated for 2 hr
with either 10 ug of CHX per ml or 1 nM IL-2 alone or a
combination of the two agents. Hybridization of the RNA
with probes generated from the inserts of each of the 18
putative clones resulted in the identification of 4 clones that
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were solely CHX-induced. For the remaining 14 clones, the
induction by the combination of IL-2 and CHX could not be
accounted for by the effects of CHX alone. Based upon the
patterns of induction and approximate sizes of the RNA
transcripts, 8 readily distinguishable and apparently unique
IL-2-induced genes were discerned among these 14. These
IL-2-induced genes were termed CR 1-8. The IL-2 induction
of these clones could be readily detected after autoradio-
graphic exposure of the Northern filters for periods ranging
from 4 hr (clone CR-8) to overnight (clone CR-2). As shown
in Fig. 2, 3 of the genes (CR-1, -3, -5) were induced by only
IL-2 alone, whereas 5 of the genes (CR-2, -4, -6, -7, -8) were
induced by CHX and IL-2. Also, it is noteworthy that the
combination of IL-2 and CHX resulted in a marked syner-
gistic induction in most instances.
Sequences ofIL-2-Induced Genes. To verify the redundancy
of the clones as estimated from Northern analysis, and to
determine the identities of the genes, the cDNA clones were
subjected to sequence analysis. The combination ofsequence
and Northern analysis revealed that the 14 putative IL-2-
induced clones consisted of eight unique genes, three of
which (CR-1, -6, -8) were isolated three times each. Searches
of the GenBank and EMBL data bases (39) with the se-
quences of the eight clones enabled the identification of two
clones. CR-4 is a recently identified DNA-binding protein,
SATBl, which binds nuclear matrix-associated DNA (40),
and CR-7 is pim-J, a previously characterized IL-2-induced
gene (26, 41) that encodes a 33-kDa cytoplasmic kinase (42).
The sequences of the other six clones did not show complete
identity with any genes in the current data bases (Table 1).
The sequence of the 0.8-kb CR-6 cDNA showed -65%
homology at the DNA level, and 40% identity to the predicted
amino acid sequences of three known genes, the human and
hamster GADD45 genes, and the mouse MyD118 gene (data
not shown). The 1.3-kb GADD45 gene was initially isolated
as a UV-irradiation-inducible gene in Chinese hamster ovary
cells (43), and the human homologue, which is 91% identical
to the hamster gene, was subsequently cloned from a human
fibroblast library (44). The 1.3-kb mouse MyD118 clone was
isolated by virtue of its induction by IL-6 in a murine myeloid
cell line (45, 46). The deduced amino acid sequences of these
proteins, which predict products of 17-18 kDa, do not exhibit
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CR-1 2.2kb
CR-5
- c-myc
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FIG. 1. Purification of thiol-labeled RNA. (A) Total cellular RNA
was isolated from 2-hr IL-2- and CHX-stimulated human peripheral
blood T cells, and thiol- and [3H]uridine labeled transcripts were
purified by passage over a phenylmercury agarose column (see text).
Column fractions were collected that contained the unbound flow-
through and the nonspecifically bound RNA (NB) and the thiol-
labeled RNA specifically eluted with 2-mercaptoethanol (E). The
specific activity of the RNA, in terms of cpm of [3H]uridine per ,ug
of RNA, was determined for the nonselected total RNA prior to
separation (NS) as well as for each of the column fractions. Data are
represented in terms of the mean ± SEM and are representative of
three separate experiments. (B) RNA samples separated as in A,
comprising the total nonselected RNA (NS), the nonspecifically
bound RNA (NB), and the specifically bound and eluted RNA (E),
were analyzed by Northern blot hybridization with a c-myc cDNA
probe (25).
CR-3
3.2kb
2.2kb
CR-4 3.5kb
1 .7kb
1.4kb
2.4kb
2.8kb
CR-7
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FIG. 2. Northern blot analysis of expression of putative IL-2-
induced genes. Go/Gi-synchronized human T cells were stimulated
for 2 hr with 10 ,ug ofCHX per ml or 1 nM IL-2 alone or a combination
of the two agents. Following electrophoresis of 15 ug of total RNA
and transfer to nitrocellulose, filters were probed with 32P-labeled
cDNA inserts of putative IL-2-induced clones.
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Table 1. Characterization of IL-2-induced genes
Insert, RNA, IL-2
Clone kb kb induction* Identityt
CR-i 1.6 2.2 24
CR-2 1.1 0.6, 1.1 7 ?
CR-3 1.8 2.2, 3.2 22 ?
CR-4 0.8 3.5 6 SATB1
CR-5 1.3 1.7 >50 ?
CR-6 0.8 1.4 5 ?
CR-7 0.7 2.4 17 pim-l
CR-8 1.3 2.8 7 ?
*Maximum fold induction (relative to unstimulated cells) of steady-
state RNA levels in human T cells during 8 hr of IL-2 stimulation
as determined from densitometric scans of Northern blots (Fig. 3).
tldentity of clone based upon searches of GenBank and EMBL data
bases (39).
significant homologies to other proteins in the current data
bases, and their functions are not yet known (44, 46).
Kinetic Analysis of IL-2-Induced Gene Expression. The ki-
netics of induction of previously characterized IL-2-
responsive genes have been found to range from those such as
c-fos, which are rapidly and transiently induced within min-
utes of IL-2 stimulation (26), to those that remain at elevated
levels through G1 to S phase entry (47). The temporal expres-
sion of the CR genes was determined by Northern blot
analysis, using RNA isolated from human IL-2R-positive
T-cell blasts after IL-2 stimulation in the presence or absence
of CHX (Fig. 3). Two of the genes, CR-1 and CR-4, exhibited
rapid induction, reaching peak levels within 1-4 hr of IL-2
stimulation and returning to basal levels after 8 hr, whereas the
other six clones remained at elevated levels for at least 8 hr in
IL-2
0 0.5 1 2 4 8
CR-1
IL-2+CHX
0 0.5 1 2 4 8
CR-2
CR-3
X0X0. Ae.d
CR-4 3.5kb
CR65 17 b
CR-7 . .; d ..SIbR...............i 2.4h b
C R-8 U~~~~~~~~~~~~~~~~~~.
FIG. 3. Kinetics of IL-2-induced gene expression. Northern blots
were prepared with 15 ,jg of total RNA isolated from Go/Gl-
synchronized human T cells stimulated for the indicated times, in
hours, with 1 nM IL-2 or IL-2 plus 10 ,ug ofCHX per ml. Filters were
probed with the cDNA inserts of the IL-2-induced clones.
the presence of continuous IL-2 treatment. The magnitude of
IL-2 induction of steady-state RNA levels ofthe clones ranged
from an -5-fold elevation of clone CR-6 to a >50-fold stim-
ulation of clone CR-5 during the interval examined (Table 1).
Several of the clones were superinduced by CHX, with an
increase observed in the magnitude and duration of the IL-2
response. The CHX effect resembles that previously de-
scribed for a number of immediate-early genes (27-29).
Responsiveness to TCR Stimulation. To determine whether
the IL-2-induced genes were also sensitive to TCR/CD3
triggering, Northern blot analysis was performed with RNA
isolated from human peripheral blood mononuclear cells
stimulated with an antibody (OKT3) specific to the CD3
component of the T-cell antigen receptor complex. To verify
that the cells were significantly activated via CD3, aliquots of
the cells were left in culture for 48 hr, after which cell cycle
progression was monitored by [3H]thymidine incorporation.
Such analysis demonstrated that the anti-CD3 stimulation
was sufficient to induce DNA replication (stimulation index
= 69). For Northern blot analysis, RNA was isolated after 2
hr of anti-CD3 treatment, so that it was possible to identify
those genes that were induced by TCR stimulation in the
absence of IL-2 effects (22). Even after autoradiographic
exposure of the Northern blots for several days, transcripts
of the majority of CR genes were undetectable, and only one
of these genes (CR-4) was found to be induced by TCR
activation (data not shown). Thus, the induction of seven of
the CR genes was unique to the IL-2 signaling pathway.
DISCUSSION
By utilizing a differential hybridization approach that incor-
porates CHX superinduction of immediate-early gene ex-
pression (27-29) in combination with a thiol-labeling proce-
dure to select for newly synthesized RNA (30, 31), we have
cloned eight IL-2-induced genes. The differential cloning
methods employed in this study are derived from those
described by Cochran et al. (27), who identified cell cycle
competence genes induced by platelet-derived growth factor
(PDGF) in murine embryonic (3T3) fibroblasts. Subse-
quently, their approach was confirmed and extended by Lau
and Nathans (28) and Almendral et al. (29), who utilized CHX
superinduction of serum-induced 3T3 cell gene expression to
further characterize competence genes. Our results with
IL-2-induced genes are in accordance with these earlier
observations, as CHX treatment considerably augmented the
IL-2 stimulation of the clones described here. In addition, the
purification of newly synthesized IL-2-induced transcripts
afforded by the thiol-labeling procedure employed in this
study (31) enabled the generation of a cDNA library from
<10% of the total cellular RNA and thus further heightened
the efficacy of the cloning procedure.
With regard to the previously described competence genes
detected in serum- and PDGF-induced fibroblasts (27-29, 48)
and lectin- and phorbol ester-treated T cells (25), it is notable
that of the eight IL-2-induced G1 progression genes reported
here, only one (CR-4) appears to also be significantly induced
during the TCR-mediated competence phase of the cell cycle.
This result suggests that, although several genes such as
c-fos, c-myc, and c-raf-J are induced during the initial Go-G1
and subsequent G1-S phase transitions (22, 23, 26), the
expression of a number of IL-2-stimulated genes is unique to
the latter event. In addition, the immediate-early genes
reported here appear to define a class distinct from the
IL-2-induced genes isolated by Sabath et al. (47). These
investigators also utilized a differential screening procedure,
but isolated genes expressed later, at the G1/S phase bound-
ary, in a murine T-helper clone that was stimulated with IL-2
for 20 hr without protein synthesis inhibitors. Of the 21
cDNAs identified, 14 were found to be already known genes,
including various metabolic enzymes and cytoskeletal pro-
2722 Cell Biology: Beadling et al.
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teins, whereas 7 represented previously unrecognized se-
quences. In addition, the expression of 3 of the clones was
actually inhibited by CHX, whereas the remainder were
insensitive to this agent. This pattern of regulation contrasts
markedly with the CHX superinduction observed with the
immediate-early IL-2-induced genes described here. More-
over, these observations indicate that IL-2 stimulates a
complex program of gene expression, ranging from those
genes induced very early in G1 through those subsequently
expressed at the G1/S phase transition.
It is anticipated that the immediate-early genes expressed
in response to IL-2 stimulation will eventually be classified
into distinct families of CR genes, based upon sensitivity of
induction by additional cytokines. Recently, the 64-kDa and
75-kDa components of the IL-2R have been found to be
members of a cytokine receptor superfamily, which includes
the receptors for erythropoietin, growth hormone, prolactin,
granulocyte and granulocyte-macrophage colony-stimulat-
ing factor, IL-3, -4, -6, and -7, as well as the 130-kDa
signal-transducing component of the IL-6 receptor (49-54).
Although the criteria utilized in defining membership in this
superfamily have primarily focused upon sequence homolo-
gies within the ligand-binding domains of the receptors, there
may also be similarities within the intracellular regions of the
receptors that are coupled to cytoplasmic signaling path-
ways. Thus, it is noteworthy that mutational analyses of the
cytoplasmic domains of the erythropoietin receptor (55, 56),
the IL-2R p75 (57), and the 130-kDa signal-transducing com-
ponent of the IL-6 receptor (54) indicate that the region
proximal to the membrane is required for efficient signal
transduction and that sequence homologies have been found
among members of the receptor family within this function-
ally important region (54). In addition, the finding that the
IL-2R p75 (57) and erythropoietin receptor (58) can confer
responsiveness to their respective ligands in IL-3-dependent
cells is suggestive of commonalities in the signaling mecha-
nisms activated by these receptors. Thus, in light of the
sequence homologies that define the cytokine receptor su-
perfamily, it will be of interest to determine to what extent the
family can be further subdivided on the basis of the compo-
sition and structure of the receptor cytoplasmic domains, the
biochemical signaling pathways triggered by the receptors,
and, finally, the patterns of induction of immediate-early
genes affected therein. Accordingly, an approach is now
available to extend the analyses of the various cytokine
receptors to encompass the characterization of their target
CR genes.
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